A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India
Atul Patel(Sterling Hospitals), Arunaloke Chakrabarti(Dev Sanskriti Vishwavidyalaya), Shivaprakash M. Rudramurthy(Post Graduate Institute of Medical Education and Research), Prakash Shastri, Valliappan Muthu(Post Graduate Institute of Medical Education and Research), J.S. Michael(Christian Medical College, Vellore), Malini R. Capoor(Safdarjang Hospital), Ritesh Agarwal(Albert Einstein College of Medicine), Rakesh Singh(Jawaharlal Institute of Post Graduate Medical Education and Research), Jayanthi Savio, Harsimran Kaur(Post Graduate Institute of Medical Education and Research), Immaculata Xess(All India Institute of Medical Sciences), R. Sardana(Indraprastha Apollo Hospitals), Sarumathi Mohan(Christian Medical College, Vellore), A. J. Kindo(Sri Ramachandra Institute of Higher Education and Research)
Cited by 408
Related Papers
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria
|Clinical & Experimental Allergy|2013|895
Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy
|Hepatology|2007|599
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature
|Mycopathologia|2021|590
Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India
|Emerging infectious diseases|2021|479